1711 – 1720 of 2179
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2006
-
Mark
Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes
(
- Contribution to journal › Article
-
Mark
Characterization of human myeloid progenitors and their differentiation
2006) In Lund University Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Weak D type 2 is the most prevalent weak D type in Portugal
(
- Contribution to journal › Article
-
Mark
Characterisation of the leukaemia-associated ETO homologues
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The Wilms' tumor gene 1 (WT1) and leukemia -new insights and further complexity
2006) In Lund University Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Prospective open-label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo- or agammaglobulinemia
(
- Contribution to journal › Article
-
Mark
The role of the leukemia-associated ETO homologue repressors in hematopoiesis
2006)(
- Thesis › Doctoral thesis (compilation)
-
Mark
The cis-AB Blood Group Phenotype: Fundamental Lessons in Glycobiology.
(
- Contribution to journal › Scientific review
-
Mark
Regarding the article "Costs associated with blood transfusion in Sweden - the societal cost of autologous, allogeneic and perioperative RBC transfusion"
(
- Contribution to journal › Letter
-
Mark
Induction chemotherapy and post-remission imatinib therapy for de Novo BCR-ABL-positive AML
(
- Contribution to journal › Article